ArticleHuman gene therapy2012

Lentiviral gene therapy against human immunodeficiency virus type 1, using a novel human TRIM21-cyclophilin A restriction factor.

Emma Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.